Emergent Biosolutions Inc (EBS)
Investing Cash Flow
-$62.00M
TTM · Period ending: · USD
EBS Investing Cash Flow
Latest reported-$62.00Mperiod ending
Latest reported-$62.00Mperiod ending
EBS TTM Cash from Investing (-$43.97M → -$62.00M)
TTM investing cash flow
High-resolution chart · PNG
EBS investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -62,000,000 | |
| 7,500,000 | |
| 69,400,000 | |
| 101,900,000 | |
| 217,300,000 | |
| 195,500,000 | |
| 125,200,000 | |
| 85,200,000 | |
| -45,700,000 | |
| 216,600,000 | |
| 212,300,000 | |
| 178,300,000 | |
| -74,400,000 | |
| -364,200,000 | |
| -381,300,000 | |
| -382,600,000 | |
| -166,200,000 | |
| -201,100,000 | |
| -225,000,000 | |
| -214,300,000 | |
| -204,800,000 | |
| -182,900,000 | |
| -151,000,000 | |
| -151,100,000 | |
| -120,700,000 | |
| -99,700,000 | |
| -96,900,000 | |
| -909,349,000 | |
| -920,107,000 | |
| -906,985,000 | |
| -897,200,000 | |
| -256,202,000 | |
| -242,920,000 | |
| -241,243,000 | |
| -249,932,000 | |
| -62,395,000 | |
| -66,616,000 | |
| -78,347,000 | |
| -76,257,000 | |
| -68,074,000 | |
| -65,027,000 | |
| -54,594,000 | |
| -45,462,000 | |
| -50,895,000 | |
| -42,166,000 | |
| -36,377,000 | |
| -210,052,000 | |
| -202,142,000 | |
| -241,338,000 | |
| -242,972,000 | |
| -67,894,000 | |
| -71,442,000 | |
| -37,047,000 | |
| -39,195,000 | |
| -40,114,000 | |
| -45,552,000 | |
| -51,339,000 | |
| -49,820,000 | |
| -53,963,000 | |
| -45,037,000 | |
| -34,639,000 | |
| -31,167,000 | |
| -23,456,000 | |
| -32,953,000 | |
| -32,824,000 | |
| -33,562,000 | |
| -33,287,000 | |
| -18,725,000 | |
| -17,364,000 | |
| -25,137,000 | |
| -30,813,000 | |
| -29,236,000 | |
| -39,169,000 | |
| -37,910,000 | |
| -43,969,000 | |
| -50,094,000 |